Search research articles
Contact Us
Filters
Showing results (341-350 of 374) with videos related to
Page
of 38
Sort By:
Frontiers in Immunology
|
January 23, 2026
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis
Ana Belén Moreno-Castaño, Sara Fernández, Helena Brillembourg, et al.
Infectious Diseases and Therapy
|
April 27, 2022
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study
Rodrigo Alonso, Ana M Camon, Celia Cardozo, et al.
The Journal of Antimicrobial Chemotherapy
|
September 2, 2021
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
Carolina Garcia-Vidal, Rodrigo Alonso, Ana M Camon, et al.
Stroke
|
March 4, 2026
Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant Data
Neshika Samarasekera, Sharon Tuck, Xia Wang, et al.
Infection
|
May 13, 2022
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
Verónica Rico-Caballero, Mariana Fernández, Juan C Hurtado, et al.
Scientific Reports
|
March 29, 2022
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
Ana M Camon, Rodrigo Alonso, Francisco J Muñoz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 3, 2020
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory Malignancies
Valentín Ortíz-Maldonado, Susana Rives, Maria Castellà, et al.
Journal for Immunotherapy of Cancer
|
December 15, 2021
Factors associated with the clinical outcome of patients with relapsed/refractory CD19<sup>+</sup> acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
Valentín Ortiz-Maldonado, Susana Rives, Marta Español-Rego, et al.
European Journal of Haematology
|
May 12, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19
Ruben Jara Rubio, Antonio José Martinez-Mellado, Jonathan Kiwitt-Cárdenas, et al.
The Lancet. Respiratory Medicine
|
March 19, 2026
Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study
Elie Azoulay, Colleen McEvoy, Pedro Castro, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 374) with videos related to
Sort By:
Page
of 38
Frontiers in Immunology
|
January 23, 2026
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis
Ana Belén Moreno-Castaño, Sara Fernández, Helena Brillembourg, et al.
Infectious Diseases and Therapy
|
April 27, 2022
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study
Rodrigo Alonso, Ana M Camon, Celia Cardozo, et al.
The Journal of Antimicrobial Chemotherapy
|
September 2, 2021
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
Carolina Garcia-Vidal, Rodrigo Alonso, Ana M Camon, et al.
Stroke
|
March 4, 2026
Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant Data
Neshika Samarasekera, Sharon Tuck, Xia Wang, et al.
Infection
|
May 13, 2022
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
Verónica Rico-Caballero, Mariana Fernández, Juan C Hurtado, et al.
Scientific Reports
|
March 29, 2022
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
Ana M Camon, Rodrigo Alonso, Francisco J Muñoz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 3, 2020
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory Malignancies
Valentín Ortíz-Maldonado, Susana Rives, Maria Castellà, et al.
Journal for Immunotherapy of Cancer
|
December 15, 2021
Factors associated with the clinical outcome of patients with relapsed/refractory CD19<sup>+</sup> acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
Valentín Ortiz-Maldonado, Susana Rives, Marta Español-Rego, et al.
European Journal of Haematology
|
May 12, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19
Ruben Jara Rubio, Antonio José Martinez-Mellado, Jonathan Kiwitt-Cárdenas, et al.
The Lancet. Respiratory Medicine
|
March 19, 2026
Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study
Elie Azoulay, Colleen McEvoy, Pedro Castro, et al.
Page
of 38